UK Companies House feature
STERIGENICS UK LIMITED
Cash
£3M
-3.4% vs 2021
Net assets
£18M
+20.8% vs 2021
Employees
76
-11.6% vs 2021
Profit before tax
£4M
+7% vs 2021
Profile
- Company number
- 02587784
- Status
- Active
- Incorporation
- 1991-03-01
- Last accounts made up
- 2023-12-31
- Account category
- FULL
- Primary SIC
- 86900
- Hubs
- UK Healthcare
Net assets
2-year trend · vs UK Healthcare median
Accounts
2-year trend · latest 2022-12-31
| Metric | Trend | 2021-12-31 | 2022-12-31 |
|---|---|---|---|
| Turnover | £14,021,000 | £16,499,000 | |
| Operating profit | £3,763,000 | £5,687,000 | |
| Profit before tax | £4,072,000 | £4,356,000 | |
| Net profit | — | — | |
| Cash | £3,199,000 | £3,091,000 | |
| Total assets less current liabilities | £29,418,000 | £32,690,000 | |
| Net assets | £14,658,000 | £17,712,000 | |
| Equity | £14,658,000 | £17,712,000 | |
| Average employees | 86 | 76 | |
| Wages | — | — |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Ernst & Young LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Given that the Company has access to the group's cash pooling facility and is financed through intercompany loans with other Group companies, confirmation of both the ability to and the intent to provide ongoing support to the extent necessary through the period to 12 months from the date of approval of the Statement of Financial Position has been obtained from the Company's ultimate parent company, Sotera Health. Having received this confirmation and considered the forecast financial position of Sotera Health and their willingness and ability to provide financial support to the Company as needed, the Director has a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.”
Significant events
- “On the 28th June 2024; The full Share Capital of Sterigenics UK Ltd was transferred to Nelson Labs NV.In consideration for the sale of the beneficial interest in the Shares, the Purchaser and the Seller entered into a loan agreement in a form agreed between themselves (the Loan Agreement), pursuant to which the Seller made available to the Purchaser a term loan in an amount of USD57,963,000”
- “In February 2025, the Company proposes to make a cash dividend distribution to its new Parent Company - Nelson Labs of $2,800,000”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
1 active · 16 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| CAUDWELL, Stephen James | Director | 2022-01-14 | Jan 1974 | British |
Show 16 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| CASEY, Patrick Joseph | Secretary | 2010-12-20 | 2018-02-08 |
| NICHOLSON, James Brett | Secretary | 1991-03-01 | 1996-02-27 |
| PEACOCK, Ronald David | Secretary | 1996-02-27 | 2010-12-20 |
| LONDON LAW SECRETARIAL LIMITED | Corporate Nominee Secretary | 1991-03-01 | 1991-03-01 |
| AESCHLIMANN, Hans | Director | 2000-11-29 | 2002-07-01 |
| BARRIE, Dirk | Director | 1994-09-22 | 2002-06-28 |
| BOSCH, Bruno | Director | 1999-05-14 | 2000-11-29 |
| GRIFFITH, Dean Ladd | Director | 1991-03-01 | 1994-06-01 |
| JAMES F, Clouser | Director | 2002-06-28 | 2004-04-30 |
| LAMBRECHTS, Jo Flor Toom | Director | 2002-06-28 | 2010-12-20 |
| MARKEY, Marc | Director | 2002-06-28 | 2011-12-31 |
| STRAIN, Peter | Director | 2011-12-31 | 2018-12-31 |
| TUTTLE, Brian John | Director | 1994-06-01 | 1999-05-14 |
| VAN MOERBEKE, Marc Etienne | Director | 1991-03-01 | 1994-09-22 |
| WYE, Adrian | Director | 2004-04-30 | 2022-01-14 |
| LONDON LAW SERVICES LIMITED | Corporate Nominee Director | 1991-03-01 | 1991-03-01 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Nelson Labs Nv | Corporate entity | Shares 75–100%, Voting 75–100% | 2024-06-28 | Active |
| Sotera Health Company | Corporate entity | Significant influence | 2024-05-01 | Ceased 2024-06-27 |
| Mr Charles Robert Kaye | Individual | Significant influence | 2016-04-06 | Ceased 2024-05-01 |
| Mr Joseph P. Landy | Individual | Significant influence | 2016-04-06 | Ceased 2020-02-01 |
Filing timeline
Last 20 of 128 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-04-08 | CS01 | confirmation-statement | confirmation statement with updates |
| 2026-04-08 | PSC07 | persons-with-significant-control | cessation of a person with significant control |
| 2026-04-08 | PSC02 | persons-with-significant-control | notification of a person with significant control |
| 2025-03-18 | CS01 | confirmation-statement | confirmation statement with updates |
| 2025-02-24 | AA | accounts | accounts with accounts type full |
| 2024-06-28 | PSC02 | persons-with-significant-control | notification of a person with significant control |
| 2024-06-28 | PSC07 | persons-with-significant-control | cessation of a person with significant control |
| 2024-03-04 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-01-19 | AAMD | accounts | accounts amended with accounts type full |
| 2023-12-29 | AA | accounts | accounts with accounts type total exemption full |
| 2023-03-14 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-03-14 | DISS40 | gazette | gazette filings brought up to date |
| 2023-03-13 | AA | accounts | accounts with accounts type full |
| 2023-02-28 | GAZ1 | gazette | gazette notice compulsory |
| 2022-04-29 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-04-22 | AA | accounts | accounts with accounts type full |
| 2022-03-24 | DISS40 | gazette | gazette filings brought up to date |
| 2022-03-10 | TM01 | officers | termination director company with name termination date |
| 2022-03-10 | AP01 | officers | appoint person director company with name date |
| 2022-03-08 | GAZ1 | gazette | gazette notice compulsory |
Credit score
Altman Z″ (private-firm) · reference 2022-12-31
2.83
SAFE
Altman Z″
- Working capital / Total assets 0.108 × 6.56 = +0.71
- Retained earnings / Total assets 0.000 × 3.26 = +0.00
- EBIT / Total assets 0.160 × 6.72 = +1.08
- Book equity / Total liabilities 0.998 × 1.05 = +1.05
Bands: > 2.6 safe · 1.1–2.6 grey · < 1.1 distress. Z″ is a public-formula baseline, not a substitute for adverse-data signals (CCJs, charges, gazette notices) — those land in a later pass.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory